308 related articles for article (PubMed ID: 3828153)
21. Expression of gamma-subunit of enolase, neuron-specific enolase, in human non-neuroendocrine tumors and derived cell lines.
Påhlman S; Esscher T; Nilsson K
Lab Invest; 1986 May; 54(5):554-60. PubMed ID: 3009968
[TBL] [Abstract][Full Text] [Related]
22. [Role of neuron specific enolase and S100 protein in evaluation of brain damage in patients resuscitated from cardiac arrest].
Miao WL; Li HL; Wang HD; Wang J; Liu H; Ren HX; Lin HY
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2007 Dec; 19(12):749-52. PubMed ID: 18093437
[TBL] [Abstract][Full Text] [Related]
23. Neuron specific enolase concentration is increased in serum and decreased in platelets of patients with active systemic sclerosis.
Massabki PS; Silva NP; Lourenço DM; Andrade LE
J Rheumatol; 2003 Dec; 30(12):2606-12. PubMed ID: 14719201
[TBL] [Abstract][Full Text] [Related]
24. Neuron-specific enolase as a marker of the severity and outcome of hypoxic ischemic encephalopathy.
Celtik C; Acunaş B; Oner N; Pala O
Brain Dev; 2004 Sep; 26(6):398-402. PubMed ID: 15275704
[TBL] [Abstract][Full Text] [Related]
25. Neuroendocrine differentiation in colorectal carcinomas.
Syversen U; Halvorsen T; Mårvik R; Waldum HL
Eur J Gastroenterol Hepatol; 1995 Jul; 7(7):667-74. PubMed ID: 8590163
[TBL] [Abstract][Full Text] [Related]
26. [Measurement of serum neuron-specific enolase levels after subarachnoid hemorrhage and intracerebral hemorrhage].
Kuroiwa T; Tanabe H; Arai M; Ohta T
No Shinkei Geka; 1994 Jun; 22(6):531-5. PubMed ID: 8015673
[TBL] [Abstract][Full Text] [Related]
27. Differential expression of neural isozymes by human medulloblastomas and gliomas and neuroectodermal cell lines.
Zeltzer PM; Schneider SL; Marangos PJ; Zweig MH
J Natl Cancer Inst; 1986 Sep; 77(3):625-31. PubMed ID: 3462406
[TBL] [Abstract][Full Text] [Related]
28. Immunohistochemical demonstration of neuron-specific enolase in neoplasms of the CNS and other tissues.
Vinores SA; Bonnin JM; Rubinstein LJ; Marangos PJ
Arch Pathol Lab Med; 1984 Jul; 108(7):536-40. PubMed ID: 6547318
[TBL] [Abstract][Full Text] [Related]
29. [Neuron-specific enolase as a new tumor marker].
Ariyoshi Y; Kato K; Ishiguro Y; Ota K; Sato T; Suchi T
Gan To Kagaku Ryoho; 1983 Aug; 10(8):1744-53. PubMed ID: 6349546
[TBL] [Abstract][Full Text] [Related]
30. [Significance of serum neuron-specific enolase levels after head injury].
Kuroiwa T; Tanabe H; Takatsuka H; Arai M; Nagasawa S; Ohta T
No Shinkei Geka; 1993 Nov; 21(11):1021-4. PubMed ID: 8255376
[TBL] [Abstract][Full Text] [Related]
31. [Cerebrospinal fluid level of aldolase C in patients with various neurological disorders: comparison with neuron-specific enolase, S-100b protein and creatine kinase BB isoenzyme].
Murayama T; Matsuoka Y; Takahashi A; Kato K; Yanagi T
Rinsho Shinkeigaku; 1989 May; 29(5):568-73. PubMed ID: 2791404
[TBL] [Abstract][Full Text] [Related]
32. Cerebrospinal fluid neuron-specific enolase in non-selected patients.
Finsterer J; Exner M; Rumpold H
Scand J Clin Lab Invest; 2004; 64(6):553-8. PubMed ID: 15370460
[TBL] [Abstract][Full Text] [Related]
33. [Electrophoretic determination of aqueous and serum neuron-specific enolase (NSE) in the diagnosis of retinoblastoma].
Wu Z; Yang H; Pan S
Zhonghua Yan Ke Za Zhi; 1996 May; 32(3):219-23. PubMed ID: 9590868
[TBL] [Abstract][Full Text] [Related]
34. [The determination of neuron-specific enolase of serum in the diagnosis and supervision of retinoblastoma].
Wu Z; Mao Y; Yang H; Pan S; Chen Z
Zhonghua Yan Ke Za Zhi; 1998 Mar; 34(2):117-20. PubMed ID: 11877170
[TBL] [Abstract][Full Text] [Related]
35. [Two cases of Creutzfeldt-Jakob disease with high neuron-specific enolase level in cerebrospinal fluid].
Jimi T; Wakayama Y; Shibuya S; Hara H; Sagawa F; Hashizume Y
Rinsho Shinkeigaku; 1989 Jan; 29(1):118-21. PubMed ID: 2663293
[TBL] [Abstract][Full Text] [Related]
36. [Diagnostic usefulness of neurospecific enolase determination in pleural fluid].
Romero S; Izquierdo M; Mauri M; Martín C; Almenar MV; García R; Padilla I
Med Clin (Barc); 1989 Nov; 93(15):568-71. PubMed ID: 2622261
[TBL] [Abstract][Full Text] [Related]
37. Cut-off levels of NSE to differentiate SCLC from NSCLC.
Satoh H; Ishikawa H; Kurishima K; Yamashita YT; Ohtsuka M; Sekizawa K
Oncol Rep; 2002; 9(3):581-3. PubMed ID: 11956631
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of serum neuron-specific enolase as a tumor marker for carcinoma of the lung.
Ariyoshi Y; Kato K; Ishiguro Y; Ota K; Sato T; Suchi T
Gan; 1983 Apr; 74(2):219-25. PubMed ID: 6305752
[TBL] [Abstract][Full Text] [Related]
39. Predictive and prognostic significance of neuron-specific enolase (NSE) in non-small cell lung cancer.
Tiseo M; Ardizzoni A; Cafferata MA; Loprevite M; Chiaramondia M; Filiberti R; Marroni P; Grossi F; Paganuzzi M
Anticancer Res; 2008; 28(1B):507-13. PubMed ID: 18383893
[TBL] [Abstract][Full Text] [Related]
40. Significance of serum neuron-specific enolase as a predictor of relapse of small cell lung cancer.
Nitta T; Fukuoka M; Masuda N; Kusunoki Y; Matsui K; Kudoh S; Hirashima T; Yana T; Ito K; Takada M
Jpn J Clin Oncol; 1995 Oct; 25(5):179-83. PubMed ID: 7474404
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
